Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
0.69
-0.02 (-2.54%)
At close: Jun 05, 2025, 3:59 PM
0.72
4.17%
Pre-market: Jun 06, 2025, 08:25 AM EDT
-2.54%
Bid 0.51
Market Cap 4.41M
Revenue (ttm) n/a
Net Income (ttm) -11.46M
EPS (ttm) -1.42
PE Ratio (ttm) -0.49
Forward PE -0.67
Analyst Buy
Ask 0.88
Volume 182,730
Avg. Volume (20D) 1,440,512
Open 0.70
Previous Close 0.71
Day's Range 0.69 - 0.74
52-Week Range 0.66 - 5.00
Beta 0.57

About DRMA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRMA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DRMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
+5.19%
Dermata shares are trading higher after the compan... Unlock content with Pro Subscription
6 months ago
+19.01%
Dermata Therapeutics shares are trading higher after the company received a notice of allowance for a U.S. patent titled "COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS (INCLUDING ACNE)"